Roche to Distribute Sepsis ImmunoScore from Prenosis
Roche will commercially distribute Prenosis Inc's Sepsis ImmunoScore, the first-ever FDA De Novo authorized AI diagnostic tool for sepsis.
Roche will commercially distribute Prenosis Inc's Sepsis ImmunoScore, the first-ever FDA De Novo authorized AI diagnostic tool for sepsis.
If EMS healthcare professionals received support making fast-paced, life-critical decisions from an AI tool, more lives could be saved.
Scientists have used artificial intelligence to discover a new antibiotic that could be used to fight a deadly, drug-resistant pathogen that strikes vulnerable hospital patients.
Known as ‘Sybil,’ the AI tool accurately predicted the risk of lung cancer for individuals with or without a significant smoking history.
Read MoreUsing artificial intelligence, researchers simplified and reinforced models that calculate fine particulate matter in urban air pollution.
Read MoreUsing artificial intelligence, Cornell University engineers have simplified and reinforced models that accurately calculate the fine particulate matter (PM2.5) contained in urban air pollution.
Read MoreA new machine learning software can be used to analyze EHRs to find common symptoms for patients diagnosed with long COVID.
Read MoreRoche and EarlySign have expanded their partnership to include AI-powered lung cancer diagnosis.
Read MoreThe FDA issued 510(k) clearance for GE Healthcare’s artificial intelligence algorithm to help clinicians assess endotracheal tube (ETT) placements.
Read MoreSiemens Healthineers has developed the Atellica COVID-19 Severity Algorithm, a model designed to help predict the potential likelihood of progression to severe disease and life-threatening multiorgan dysfunction in COVID-19 patients.
Read MoreAn artificial intelligence (AI) program can spot signs of lung cancer on CT scans a year before they can be diagnosed with existing methods.
Read MoreA research team has been able to reliably identify tumor type using a combination of infrared microscopy and artificial intelligence.
Read MoreScientists are using AI to pinpoint gene expression patterns associated with viral infections to build a map that defines patients’ immune responses.
Read MoreRoyal Philips and healthcare-AI developer Orbita Inc will co-create next-generation conversational virtual assistants for Philips consumer health and patient support applications.
Read MorePhysicians may one day use a machine learning model, called deep learning, to guide their treatment decisions for lung cancer patients
Read More